On October 4, 2021 VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, reported that members of the management team will participate in analyst-led fireside chats at the following upcoming investor conferences (Press release, VBI Vaccines, OCT 4, 2021, View Source [SID1234590747]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim 2nd Annual Vaccines & Infectious Disease Conference

Discussion to be held with Evan Wang – Equity Research Senior Associate

Date: Tuesday, October 5, 2021
Time: 10:30-10:55 AM ET
Webcast Link: View Source
H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference

Discussion to be held with Patrick Trucchio – Managing Director, Senior Healthcare Analyst

Date: Wednesday, October 13, 2021
Time: 4-4:30 PM ET
Webcast Link: View Source
Live webcasts of the presentations will also be available on the Investors page of VBI’s website at: View Source A replay of each webcast will be archived on the Company’s website following the presentation.